Jump to content

RxTrials Institute Drug Pipeline Alert (Pituitary)


Recommended Posts

  • Chief Cushie



RxTrials Institute Drug Pipeline Alert

Jan. 16, 2008 | Vol. 6 No. 3


Ipsen, The Salk Institute Sign Strategic Research Agreement


French drugmaker Ipsen and California's The Salk Institute for Biological Studies will sign a memorandum of understanding setting the framework for the creation of the Ipsen Life Sciences Program at The Salk Institute.


Ipsen will provide funding for research programs in the field of proliferative diseases with a particular emphasis on novel therapeutic concepts for the treatment of pituitary adenomas, the company said.

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...